StockpollyBeta
Get App
Popularity #3,337
ANIK · NASDAQ · Medical - Specialties

Anika Therapeutics (ANIK)

Makes HA-based orthopedic products for OA pain management and regenerative procedures.

$20.25
vs last close−0.64 (−3.04%)

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue4143413139−1262828313033
Cost of revenue1717161037−24111412111111
Gross profit25262520123151416191921
3390302229−5191919192418
Research & development888773667677
Selling, general & administrative2520221619−5131212121811
Other expenses062003−3000000
Operating income−8−64−5−2−2828−4−4−31−53
111101001010
Interest income11—100000000
Other non-operating income0−62−1−10300−10−10
Income before tax−7−63−4−1−2829−4−4−21−53
Income tax expense000123011−100
Net income from continuing operations−7−63−5−3−3026−4−5−32−53
Discontinued operations000200−111−200
Other adjustments00000−48000000
Net income−7−63−50−30−22−5−4−20−53
EPS, basic−$0.45−$4.30−$0.31−$0.01−$2.03−$1.50−$0.34−$0.28−$0.16$0.02−$0.37$0.24
EPS, diluted−$0.45−$4.30−$0.31−$0.01−$2.03−$1.50−$0.34−$0.28−$0.16$0.02−$0.37$0.24
Weighted average shares, basic151515151515141414141413
Weighted average shares, diluted151515151515141414151413
EBITDA−42−21−2527−2−2−12−35
Depreciation & amortization443222221112
EBIT−8−2−4−1−2825−4−4−21−53